The Wegovy pill, explained: 10 things to know about the weight loss drug you can now swallow

ByBNW TEAM

For years, the most talked-about weight loss medicine in the world came only as a weekly injection. That has changed. The UK has become the first country in Europe to approve a daily tablet version of Wegovy, opening the treatment to people who were never going to pick up a needle. The science is the same; the delivery is not. It is a shift that could widen access to a drug already credited with transforming obesity treatment, and one that arrives amid soaring demand and a crackdown on counterfeit sellers. Here are ten things to know about the medicine now reshaping how weight loss treatment reaches the public.

1. It is the same drug, in a pill.

The Wegovy pill contains semaglutide, exactly the same active ingredient as the familiar Wegovy injection and the diabetes drug Ozempic. It belongs to a class called GLP-1 receptor agonists, which mimic a natural gut hormone to reduce appetite and slow how quickly the stomach empties. Nothing about how the medicine works has changed. What has changed is that you can now swallow it rather than inject it.

2. It is a genuine UK first.

On 11 June 2026, the UK’s medicines regulator approved the Wegovy pill, making Britain the first country in Europe to license an oral version of semaglutide for weight loss. That is the heart of the story: not a new drug, but a new and far more accessible way of taking one that has already proven itself.

3. The results rival the injection.

In its pivotal trial, the 25mg pill produced around 14% average weight loss over 64 weeks, against roughly 15% for the standard 2.4mg weekly injection in earlier studies. The figures come from separate trials rather than a head-to-head, but they place the tablet firmly in the same league. For a pill, that is a significant achievement. Notably, the trial also found that around three in ten people on the pill lost 20% or more of their body weight, the kind of result once associated only with the strongest injectables. As with any of these drugs, the average masks a wide range: some people respond dramatically, others more modestly, and adherence to the daily routine plays a real part in where someone lands.

The Wegovy pill at a glance: a UK-first oral GLP-1, with results close to the injection.

4. There is a strict morning routine.

This is the catch. The tablet must be taken on waking, on an empty stomach, with no more than about 120ml of plain water, followed by a 30-minute wait before any food, drink or other medication. That window is not a suggestion. Miss it and the medicine does not absorb properly, so the routine is the price of the convenience. In practice, most people take the tablet the moment they wake, keep a small glass of water by the bed, and let the half hour pass while they shower and dress. For those with steady mornings it quickly becomes automatic; for shift workers, frequent travellers or anyone whose wake-up time jumps around, it is a real commitment to weigh up honestly before starting.

5. Yes, that includes coffee.

The 30-minute wait applies to coffee and tea as much as to food. For many people that is the genuinely hard part of the routine, but it matters: anything other than that small sip of water inside the window reduces how much of the drug reaches the bloodstream.

6. A clever bit of chemistry makes it work.

Semaglutide is a peptide that stomach acid would normally destroy, which is why it has always been injected. The tablet survives only because it contains an absorption enhancer called SNAC, which briefly protects the molecule and helps it cross the stomach wall. SNAC is the reason an oral version exists at all, and the reason the empty-stomach rule is so important.

7. The dose looks huge next to the injection.

The pill’s maintenance dose is 25mg daily, against just 2.4mg weekly for the injection. That is not because the tablet is stronger. Oral semaglutide has a bioavailability of only about 1%, compared with around 94% for the injection, so the much larger oral dose is simply compensating for how little survives digestion. It is a quirk that often alarms patients at first glance, but the amount of active drug actually reaching the bloodstream is broadly similar between the two. The big number on the box is doing the work of getting past the gut, not delivering a heavier hit of medicine.

8. No needles, and no fridge.

Two practical advantages come with the tablet. There is no injection, which removes the single biggest barrier for needle-averse patients, and unlike the injection pens, the tablet is stored at room temperature and needs no refrigeration. That makes it easier to travel with and simpler to keep at home. The needle point should not be underestimated: for a meaningful share of people, the prospect of injecting themselves every week was always the dealbreaker, and a swallowable version brings effective treatment within reach of those who would otherwise have gone without. The trade-off, of course, is the daily discipline the injection never demanded.

9. The side effects are familiar.

Because it is the same drug, the side-effect profile mirrors the injection. The most common complaints are gastrointestinal, nausea, constipation and the like, and they tend to be at their worst during the dose build-up before easing over time. The medication is started low and increased gradually for exactly this reason. Anyone with certain thyroid or pancreatic histories is generally advised against it, which is one of the reasons a proper clinical assessment matters before starting.

10. It is private first, and you can switch.

As with the injections before it, the Wegovy pill is reaching the public through regulated private providers first, with wider NHS availability expected to follow after the usual assessments. Patients are also not locked in: with clinical guidance it is possible to move between the 25mg pill and the 2.4mg injection, usually starting the new form about a week after the last dose of the old one. The choice often comes down to lifestyle, a steady morning routine suits the pill, while erratic schedules may favour the weekly jab, and it is worth taking time to compare how the pill and injection differ before deciding. Either way, anyone considering it should go through a properly regulated UK clinic with prescriber oversight, rather than the unregulated sellers that have flooded the weight loss market, and treat the medication as one part of a plan that still includes sensible eating and activity.

The bottom line

The Wegovy pill does not replace the injection so much as widen the door. It offers comparable results without a needle, at the cost of a strict daily routine, and for a large group of people who were put off by injecting, that trade is well worth making. The arrival of an effective oral GLP-1 is a milestone, and with the UK first in Europe to license it, this is one health story likely to run well beyond its launch.

It also marks the start of a broader shift. Oral versions of these drugs are widely expected to become the next battleground in weight loss medicine, with rival manufacturers racing to bring their own tablets to market. For patients, that competition should eventually mean more choice and, in time, potentially lower prices. For now, the Wegovy pill is the first of its kind to reach the public in Europe, and how its launch unfolds, the demand, the access debate, the pressure on the NHS to follow, will shape what comes next. The needle is no longer the only way in, and that alone makes this a turning point worth watching.

Sources

  • UK / MHRA. First GLP-1 tablet for weight loss approved in the UK, 11 June 2026. https://www.gov.uk/government/news/first-glp-1-tablet-for-weight-loss-approved-in-the-uk
  • American College of Cardiology. OASIS 4: oral semaglutide 25 mg weight-loss results. 2025. https://www.acc.org/latest-in-cardiology/journal-scans/2025/09/24/16/40/oasis-4
  • Peptide Nerds. Oral vs injectable semaglutide: bioavailability and dosing. 2026. https://peptidenerds.com/blog/oral-semaglutide-vs-injectable-weight-loss
  • Wegovy pill: how the oral tablet compares to the injection. https://www.joinvoy.com/weight-loss/medications/wegovy-pill